Covid-19 roundup: US buys more of the on­ly an­ti­body that works against Omi­cron; BioN­Tech taps AI to de­tect new vari­ants faster

Glax­o­SmithK­line and Vir’s mon­o­clon­al an­ti­body sotro­vimab is still the on­ly mAb treat­ment that works against the Omi­cron vari­ant, and the US on Tues­day boost­ed its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.